Sandoz Leadership
Under the leadership of Richard Saynor, the Sandoz Executive Committee (SEC) is responsible for overseeing the business operations of Sandoz. The SEC is made up of a diverse team of leaders with extensive experience in the generic pharmaceutical and biopharmaceutical industry. Each member of the SEC represents a specific region, business unit or global function. They share a commitment to helping people around the world access high quality medicine.
Richard Saynor
CEO, Sandoz
Francisco Ballester
Head of International Region
Martin Bischof
Ad interim, Head of Europe
Pierre Bourdage
Ad interim, Global Head of Biopharmaceuticals
Andreas Brutsche
External Supply Operations, Novartis Technical Operations
Philippe Deecke
Chief Financial Officer
Subodh Deshmukh
Global Head of Product Development
Andre Heeg
Head of Digital
Steffen Kurzawa
Global Head of Communications
Carol Lynch
President of Sandoz US and Head of North America
Inge Maes
Global Head People & Organization
Christine Miller
Head Global Portfolio
Christian Pawlu
Global Head of Divisional Strategy
Ingrid Sollerer
General Counsel & Global Head of Legal
Joy Xu
Global Head of Human Resources